India — Fruit and Fruit Products — Citrus

← back to leaderboard

India received 5 FDA import refusals in Citrus, part of Fruit and Fruit Products between 2023-Q1 and 2025-Q3. Volume is roughly flat year-on-year. The most-cited issues are substitution, bulking agent added, and ingredients not listed. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Key figures

Hazard or paperwork
Of these, 2 were hazard refusals and 3 were paperwork refusals.

Quarterly refusals, last 11 quarters

2023-Q1: 1 paperwork 1 2023-Q1 2023-Q1: 1 — 0 hazard, 1 paperwork 0 2023-Q2 2023-Q2: 0 — 0 hazard, 0 paperwork 0 2023-Q3 2023-Q3: 0 — 0 hazard, 0 paperwork 2023-Q4: 2 paperwork 2 2023-Q4 2023-Q4: 2 — 0 hazard, 2 paperwork 0 2024-Q1 2024-Q1: 0 — 0 hazard, 0 paperwork 0 2024-Q2 2024-Q2: 0 — 0 hazard, 0 paperwork 0 2024-Q3 2024-Q3: 0 — 0 hazard, 0 paperwork 0 2024-Q4 2024-Q4: 0 — 0 hazard, 0 paperwork 2025-Q1: 1 hazard 1 2025-Q1 2025-Q1: 1 — 1 hazard, 0 paperwork 0 2025-Q2 2025-Q2: 0 — 0 hazard, 0 paperwork 2025-Q3: 1 hazard 1 2025-Q3 2025-Q3: 1 — 1 hazard, 0 paperwork

hazard findings labelling & registration

Show the numbers
QuarterRefusalsHazardPaperwork
2023-Q1101
2023-Q2000
2023-Q3000
2023-Q4202
2024-Q1000
2024-Q2000
2024-Q3000
2024-Q4000
2025-Q1110
2025-Q2000
2025-Q3110

Recent refusals

Data and downloads

Download all 5 entries (CSV) — every refusal behind this page, with its import division, FDA product code, charges and whether it was a hazard finding or paperwork.

The file holds entries up to 2025-08-11. To get new ones for India by email, watch India.